Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1576

1.

Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease.

Kivipelto M, Mangialasche F, Ngandu T.

Nat Rev Neurol. 2018 Oct 5. doi: 10.1038/s41582-018-0070-3. [Epub ahead of print] Review.

PMID:
30291317
2.
3.

Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau.

Audrain M, Haure-Mirande JV, Wang M, Kim SH, Fanutza T, Chakrabarty P, Fraser P, St George-Hyslop PH, Golde TE, Blitzer RD, Schadt EE, Zhang B, Ehrlich ME, Gandy S.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0258-3. [Epub ahead of print]

PMID:
30283031
4.

Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study.

Jiskoot LC, Bocchetta M, Nicholas JM, Cash DM, Thomas D, Modat M, Ourselin S, Rombouts SARB, Dopper EGP, Meeter LH, Panman JL, van Minkelen R, van der Ende EL, Donker Kaat L, Pijnenburg YAL, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe J, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S; Genetic Frontotemporal dementia Initiative (GENFI), Papma JM, van Swieten JC, Rohrer JD.

Ann Clin Transl Neurol. 2018 Jul 11;5(9):1025-1036. doi: 10.1002/acn3.601. eCollection 2018 Sep.

5.

Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.

Abreha MH, Dammer EB, Ping L, Zhang T, Duong DM, Gearing M, Lah JJ, Levey AI, Seyfried NT.

Proteomics. 2018 Sep 19:e1800108. doi: 10.1002/pmic.201800108. [Epub ahead of print]

PMID:
30230243
6.

Cinnamaldehyde Improves Lifespan and Healthspan in Drosophila melanogaster Models for Alzheimer's Disease.

Pham HM, Xu A, Schriner SE, Sevrioukov EA, Jafari M.

Biomed Res Int. 2018 Aug 29;2018:3570830. doi: 10.1155/2018/3570830. eCollection 2018.

7.

The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.

Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D, Hyman BT.

J Neuroinflammation. 2018 Sep 18;15(1):269. doi: 10.1186/s12974-018-1309-z.

8.

Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.

Liesinger AM, Graff-Radford NR, Duara R, Carter RE, Hanna Al-Shaikh FS, Koga S, Hinkle KM, DiLello SK, Johnson MF, Aziz A, Ertekin-Taner N, Ross OA, Dickson DW, Murray ME.

Acta Neuropathol. 2018 Sep 15. doi: 10.1007/s00401-018-1908-x. [Epub ahead of print]

PMID:
30219939
9.

Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial.

Lilamand M, Cesari M, Cantet C, Payoux P, Andrieu S, Vellas B; and the MAPT/DSA study group.

J Am Geriatr Soc. 2018 Oct;66(10):1940-1947. doi: 10.1111/jgs.15497. Epub 2018 Sep 12.

PMID:
30207586
10.

Monogenic inheritance in early-onset dementia: illustration in Alzheimer's disease and frontotemporal lobar dementia.

Barbier M, Wallon D, Le Ber I.

Geriatr Psychol Neuropsychiatr Vieil. 2018 Sep 1;16(3):289-297. doi: 10.1684/pnv.2018.0744.

PMID:
30168435
11.

Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems.

Balaji V, Kaniyappan S, Mandelkow E, Wang Y, Mandelkow EM.

Autophagy. 2018 Sep 13:1-16. doi: 10.1080/15548627.2018.1509607. [Epub ahead of print]

PMID:
30145931
12.

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.

Woollacott IOC, Nicholas JM, Heslegrave A, Heller C, Foiani MS, Dick KM, Russell LL, Paterson RW, Keshavan A, Fox NC, Warren JD, Schott JM, Zetterberg H, Rohrer JD.

Alzheimers Res Ther. 2018 Aug 16;10(1):79. doi: 10.1186/s13195-018-0405-8.

13.

Three VCP Mutations in Patients with Frontotemporal Dementia.

Wong TH, Pottier C, Hondius DC, Meeter LHH, van Rooij JGJ, Melhem S; Netherlands Brain bank, van Minkelen R, van Duijn CM, Rozemuller AJM, Seelaar H, Rademakers R, van Swieten JC.

J Alzheimers Dis. 2018;65(4):1139-1146. doi: 10.3233/JAD-180301.

PMID:
30103325
14.

Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.

Feis RA, Bouts MJRJ, Panman JL, Jiskoot LC, Dopper EGP, Schouten TM, de Vos F, van der Grond J, van Swieten JC, Rombouts SARB.

Neuroimage Clin. 2018 Jul 17;20:188-196. doi: 10.1016/j.nicl.2018.07.014. eCollection 2018.

15.

The Whole Exome Sequencing Clarifies the Genotype- Phenotype Correlations in Patients with Early-Onset Dementia.

Xu Y, Liu X, Shen J, Tian W, Fang R, Li B, Ma J, Cao L, Chen S, Li G, Tang H.

Aging Dis. 2018 Aug 1;9(4):696-705. doi: 10.14336/AD.2018.0208. eCollection 2018 Aug.

16.

Frontotemporal Dementia-Associated N279K Tau Mutation Localizes at the Nuclear Compartment.

Ritter ML, Avila J, García-Escudero V, Hernández F, Pérez M.

Front Cell Neurosci. 2018 Jul 12;12:202. doi: 10.3389/fncel.2018.00202. eCollection 2018.

17.

Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.

Abner EL, Neltner JH, Jicha GA, Patel E, Anderson SL, Wilcock DM, Van Eldik LJ, Nelson PT.

J Alzheimers Dis. 2018;64(4):1307-1324. doi: 10.3233/JAD-180514.

PMID:
30040735
18.

Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.

García-León JA, Cabrera-Socorro A, Eggermont K, Swijsen A, Terryn J, Fazal R, Nami F, Ordovás L, Quiles A, Lluis F, Serneels L, Wierda K, Sierksma A, Kreir M, Pestana F, Van Damme P, De Strooper B, Thorrez L, Ebneth A, Verfaillie CM.

Alzheimers Dement. 2018 Oct;14(10):1261-1280. doi: 10.1016/j.jalz.2018.05.007. Epub 2018 Jul 20.

19.

Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.

Grothe MJ, Sepulcre J, Gonzalez-Escamilla G, Jelistratova I, Schöll M, Hansson O, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2018 Sep 1;141(9):2755-2771. doi: 10.1093/brain/awy189.

20.

Chemogenomics Systems Pharmacology Mapping of Potential Drug Targets for Treatment of Traumatic Brain Injury.

Wang L, Ma S, Hu Z, McGuire TF, Xie XS.

J Neurotrauma. 2018 Sep 6. doi: 10.1089/neu.2018.5757. [Epub ahead of print]

PMID:
30014763

Supplemental Content

Loading ...
Support Center